More than 15 years GMP Factory Suppy 99.5% 3,20-Dioxopregna-1,4,9(11),16-tetraen-21-yl acetate Medical Grade CAS37413-91-5
37413-91-5
Pharmaceutical Grade
99.5%
shanghai
Honour
25kg/drum, customized
2024-09-22
Semaglutide,Tirzepatide,API,Enzyme
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
21-(Acetyloxy)pregna-1,4,9(11),16-tetraene-3,20-dione
Other Name:Pregna-1,4,9(11),16-tetraene-3,20-dione,21-(acetyloxy)-;Pregna-1,4,9(11),16-tetraene-3,20-dione,21-hydroxy-,acetate;21-(Acetyloxy)pregna-1,4,9(11),16-tetraene-3,20-dione;21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione;21-Hydroxy-1,4,9(11)-tetraene 21-acetate;2-((10S,13S,14S)-10,13-Dimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate;3,20-Dioxopregna-1,4,9(11),16-tetraen-21-yl acetate
CAS No.:37413-91-5
Molecular Formula:C23H26O4
InChIKeys:InChIKey=UFEOMHFPJREVTP-PTRHGPIFSA-N
Molecular Weight:366.450
Exact Mass:366.45
EC Number:253-497-3
DSSTox ID:DTXSID60190855
Categories:
Characteristics-
PSA:
60.44000
XLogP3:3.48
Density:1.2±0.1 g/cm3
Melting Point:172-174 °C @ Solvent: Methanol, Acetone
Boiling Point:534.6±50.0 °C at 760 mmHg
Flash Point:233.0±30.2 °C
Refractive Index:1.585
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide,Tirzepatide,API,Enzyme
-
Location:
Unit ST-308, No. 329, Jiahe Road, Siming District, Xiamen
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
11-50
-
Year of Establishment:
2018
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product




